- This Week in IsraelTech
- Posts
- Synthetic Biology: From Pharma To Fashion
Synthetic Biology: From Pharma To Fashion
This Week in IsraelTech - Turning DNA Into Everyday Products ft. Eran Miller from MNDL Bio
Turning DNA Into Everyday Products ft. Eran Miller from MNDL Bio
DNA Is the New Assembly Line
From insulin to spider silk, synthetic biology is already reshaping what we eat, wear, and use - and you probably don’t even know it.
The next leap? Taking biomanufacturing beyond pharma and into everything from sustainable food to lab-grown materials. That’s where MNDL Bio comes in, solving the biggest bottleneck: making DNA engineering faster, smarter, and cheaper.
We sat down with Eran Miller - passionate about impact and sustainable development, with 10 years in international business development and 12 years in R&D. He’s bridging deep technical expertise with entrepreneurial vision to make synthetic biology tools accessible, affordable, and ready for the mainstream.
We talk opportunities, ethical hazards, and why this “living manufacturing” could rival AI in impact.
Would you trust products made by engineered bacteria or yeast?
Hosted by Yoel Israel

Shorts of the Week
FinTech’s Next Wave Is Harder To See ft. Adi Levanon of Sealh Ventures
Parents Ask: How Do You Steer A Kid Toward Cybersecurity? ft Tal Zamir of Perception Point
Why Are There So Few Ethiopian Founders in Israel? ft. Chen Shmilo of The 8200 Alumni Association
This Week in Israeli Tech News
IVIX Raises $60M to Track Global Financial Crime
IVIX gives governments AI-native tools to detect tax evasion and hidden transactions across blockchains, rentals, and e-commerce.
Thoma Bravo in Talks to Acquire Armis for $5B
Armis, born in Tel Aviv, is now a global leader in securing critical infrastructure and medical devices.
Controp Lands $600M+ Valuation in Rafael Sale Talks
Controp designs advanced electro-optics for drones, aircraft, and border defense, with AeroVironment eyeing a major stake.
Nir Zuk Steps Down From Palo Alto After 20 Years
The Unit 8200 alum and Palo Alto founder exits weeks after sealing the $25B CyberArk acquisition.
Seemplicity Raises $50M to Automate Exposure Management with AI
Seemplicity, an Israeli cybersecurity startup, has secured a $50M Series B round to enhance its AI-powered platform, helping enterprises manage security vulnerabilities more efficiently. The platform processes over 1.5 billion security findings daily, enabling security teams to focus on high-priority risks.
Culture Corner
U.S. Seeks $3.5B to Replenish Israel’s Missile Defense Amid Ongoing Threats
According to a Bloomberg report, the U.S. Defense Department has requested more than $3.5 billion to restock missile interceptors and other systems used to protect Israel during recent clashes with Iran. Pentagon budget documents cite operations conducted alongside Israel to defend its territory, personnel, and assets, particularly during the April 2024 attack when Iran launched over 300 missiles and drones, most of which were intercepted by Israel, the U.S., and other allies. Around $1 billion of the request covers a single interceptor type used in that assault. The documents appear to have been drafted before the June 2024 war, yet they also include reimbursement for U.S. Standard Missile-3 (SM-3) interceptors—both newly produced rounds and those fired in combat. Bloomberg notes that SM-3s were used by American forces in the June fighting. This funding request is separate from the $4.2 billion in weapons and equipment Washington supplied to Israel between the Hamas-led October 7, 2023, assault and May 2024, and stems from a $14 billion aid package Congress approved last year.
Our Replies Are OPEN!
We love hearing from you! Got a comment on a video? A news tip we should highlight? Drop us a message - your voice is crucial in helping us democratize the Israeli tech ecosystem, and we’re listening!